Companies / Nykode Therapeutics
Nykode Therapeutics
Oslo, Norway
Nykode Therapeutics develops immunotherapy treatments, including a platform built around the Vaccibody molecule, to treat diseases such as cancer and autoimmune diseases.
Nykode Therapeutics, based in Oslo, Norway, has 2 investors on file, among them Radforsk and Sarsia. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on fileMore from Radforsk
6 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
More from Sarsia
26 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (32%), Industrial & Manufacturing (16%), AI & Machine Learning (14%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Nykode Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Radforsk adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/nykode.com/investors
# also
GET /v1/companies/nykode.com
GET /v1/companies/nykode.com/news